Learn More
Medchemexpress LLC Inlexisertib (DCC-3116) | 2543673-19-2 | 99.3% | 535.60 g/mol | C26H36F3N7O2 | 10 MG

Supplier: Medchemexpress LLC HY16069910MG
Inlexisertib is a small-molecule, orally active inhibitor of the ULK1 and ULK2 kinases used in preclinical cancer research to inhibit autophagy and sensitize KRAS-mutant tumors to targeted therapies.
- Orally active ULK1/2 inhibitor that blocks autophagy.
- Demonstrated antiproliferative activity in KRAS-mutant cell lines and tumor growth inhibition in non-small cell lung cancer models.
- Molecular formula C26H36F3N7O2 and molecular weight 535.60 g/mol.
- High supplied purity (~99.3%).
- Available in multiple solid pack sizes and as a 10 mM solution in DMSO for in vitro studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.